This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Jerry Fong, PhD
Associate Director, Cancer Biology and Pharmacology at Rakuten Medical

Agenda Sessions

  • IlluminoxTM - A Novel, Tumor-targeted Treatment Platform that Ignites Local and Systemic Anti-cancer Immune Responses through Selective Cancer and Immunosuppressive Cell Destruction.

    On Demand
  • LIVE Moderated Panel Discussion and Q&A Including Audience Interaction with Speakers from On-Demand SESSION #8: POTENTIATING ANTIBODIES THROUGH CONJUGATION - To prepare for this discussion/Q&A, attendees should view the presentations from Session #8 in the Watch On-Demand Sessions Tab prior to this session

    15:45